Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,020.00
Bid: 1,955.00
Ask: 2,040.00
Change: 70.00 (3.59%)
Spread: 85.00 (4.348%)
Open: 2,050.00
High: 2,050.00
Low: 1,955.00
Prev. Close: 1,950.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Dec 2020 07:00

RNS Number : 9871H
S & U PLC
09 December 2020
 

 

9 December 2020

 

S&U plc

("S&U" or "the Group")

 

TRADING STATEMENT

 

S&U, the specialist motor finance and property bridging lender, announces its trading update for the period from the 1st August 2020 to the 8th December 2020. This period has seen a rebound in Group trading and profitability, despite a slowdown in November resulting from the renewed Covid-19 lockdown and uncertainties relating to its planned aftermath. We have continued to focus on quality at both Advantage and Aspen and demand for motor and bridging loans over the period has been healthy.

 

The business is resilient and financially strong and, notwithstanding constantly changing Government guidance on Covid-19 restrictions, we are confident of a resumption of our usual rates of growth in the first half of next year.

 

MOTOR FINANCE

 

The demand for good quality used cars and their auction values has recovered well during the period. Overall used car transactions rose by 4.4% in the UK in the third quarter, at 2,160,000 vehicles. Indeed, recent FLA figures showed the strongest used car price growth in a decade. At Advantage, our motor finance subsidiary, this was reflected in an improved rate of transactions in the period. However, Advantage's temporary withdrawal from the self-employed and lower tier sectors of the market, means that despite the recent market improvement, current net receivables are at £253 million (£280 million: 2019) and current live customer numbers are at 63,000, slightly less than last year's 63,500.

 

Undoubtedly the Covid-19 epidemic is prompting an unease about public transport and a general desire for the security and convenience of a wholly-owned (and unshared) vehicle. Further, considerations of value in uncertain times favour the smaller used car sector in which Advantage specialises.

 

These trends have been reflected in Advantage's robust receivables quality. Despite imposition by the Financial Conduct Authority of further and extended customer repayment "holidays" in the period, monthly collections remain within 7% of last year's and are improving as customers return to normal payment. Thus, the third quarter saw collection rates at 87.5% of due (2019: 94%) against 74.1% in the second quarter. Whilst 12,900 customers were still on payment "holiday" at the end of July, this has fallen to below 5,000 currently. New customer quality and early repayments are performing very well.

 

Advantage are using the Covid-19 hiatus to prepare for recovery and to embed long term operational improvements. Current examples include developing affinity partnerships, still closer systems integration with our introducer partners to improve transaction rates, and further customer service and affordability analysis which will drive Advantage's already excellent Trustpilot customer satisfaction ratings even higher.

 

 

Aspen Bridging Finance

 

Aspen Bridging has in the period achieved the landmark £100 million of lending since it was founded. Whilst prudently viewing the residential market with their customary caution, Aspen has seen transactions improve considerably over the period. Hence current net receivables stand at £29.6 million against just £18.5 million at half-year.

 

Loan quality has strengthened too. A sustained focus on overdue and extended customers has seen their number successfully reduce in the period, meaning that in the current live book only two accounts are just past due with no defaults remaining. This improvement in quality has seen an improvement in profitability and provides a firm base for future growth.

 

Funding

 

Significant cash generation at Advantage, offset by net investment in Aspen of £10.6 million since half year and payment to shareholders of our first interim dividend, means current Group borrowings are at £103 million against just £108 million in July. With Group facilities at over £130 million and gearing at only 58%, this gives S&U its habitually firm base for the accelerated growth we anticipate may be appropriate next year.

 

Outlook

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U chairman, said:

 

"Despite the persistent drag anchor that is Covid-19 and the possibly inevitable zigzagging in Government policy to deal with it, S&U is in fine fettle. Aside from our traditional strengths - experience, conservative financial policies and sustainable growth - most of all I pay tribute to the dedication and sensible ambition of our people. To paraphrase Liverpool FC's Jurgen Klopp, whatever Covid-19 brings "we deal with it, recover, prepare and go again". Hence our great confidence in the future."

 

 

 

For further information, please contact:

 

S&U

Anthony Coombs, Chairman 0121 705 7777

 

Newgate Communications

Bob Huxford, Megan Kovak, Tom Carnegie 020 7653 9848

 

Peel Hunt

Adrian Trimmings, Andrew Buchanan, Rishi Shah 020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIBDDDDGDGGI
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.